Allovir Inc (NASDAQ:ALVR)
| 5.97 Delayed Data As of Jan 26 |  +0.38 / +6.80%Today’s Change | 3.17 Today|||52-Week Range 10.29 | +16.37% Year-to-Date |
Latest ALVR News | Press Releases
| AlloVir, Inc. (ALVR) Upgraded to Buy: Here's What You Should Know Jan 25 / Zacks.com - Paid Partner Content | Are Medical Stocks Lagging Adicet Bio (ACET) This Year? Jan 25 / Zacks.com - Paid Partner Content |
| How Much Upside is Left in AlloVir, Inc. (ALVR)? Wall Street Analysts Think 355.8% Jan 25 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.59 |
| Today’s open | 5.70 |
| Day’s range | 5.64 - 6.05 |
| Volume | 325,612 |
| Average volume (3 months) | 289,005 |
| Market cap | $489.1M |
Data as of 3:59pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | -5.57% |
| Earnings growth (this year) | +16.92% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.48 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 9, 2023 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$172.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
